AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.240
-0.030 (-0.92%)
Nov 20, 2024, 4:00 PM EST - Market closed
AC Immune Market Cap
AC Immune has a market cap or net worth of $320.57 million as of November 21, 2024. Its market cap has increased by 39.13% in one year.
Market Cap
320.57M
Enterprise Value
137.29M
1-Year Change
39.13%
Ranking
Category
Stock Price
$3.24
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $320.57M, a decrease of -63.05%. That is a compound annual growth rate of -11.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 323.50M | -23.63% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Codexis | 319.81M |
| COMPASS Pathways | 318.84M |
| Absci | 318.15M |
| Nyxoah | 316.15M |
| Delcath Systems | 311.42M |
| Cerus | 310.14M |
| Lyell Immunopharma | 309.93M |
| Sanara MedTech | 309.17M |